We value your privacy
We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.
Clinical Trials
0
0 active
Approvals
Total approvals
Agencies
Regulatory bodies
Founded
N/A
No trial phase data available
No trial data available
No approval data available
• Neuspera's novel batteryless sacral neuromodulation system demonstrates 84% response rate in treating urgency urinary incontinence at 6-month follow-up. • The innovative device eliminates the need for a battery implant, requiring only a single incision for placement and utilizing external power transmission through a wearable disc. • Clinical outcomes match established efficacy benchmarks for traditional sacral neuromodulation therapy while offering a less invasive surgical approach.
